https://www.nasdaq.com/press-release/acutus-medical-initiates-ce-mark-study-for-focal-pulsed-field-ablation-therapy-to
https://www.nasdaq.com/press-release/acutus-medical-reports-third-quarter-2021-financial-results-2021-11-11
https://www.nasdaq.com/press-release/acutus-medical-to-announce-third-quarter-2021-financial-results-2021-10-28
https://www.nasdaq.com/press-release/acutus-medical-appoints-niamh-pellegrini-to-board-of-directors-2021-08-12
https://www.nasdaq.com/press-release/acutus-medical-reports-second-quarter-2021-financial-results-2021-08-12
https://www.nasdaq.com/press-release/acqmap-8-acutus-medicals-innovative-suite-of-software-upgrades-receives-fda-clearance
https://www.nasdaq.com/press-release/acutus-medical-to-participate-at-the-6th-annual-needham-virtual-med-tech-diagnostics
https://www.nasdaq.com/press-release/acutus-medical-to-announce-second-quarter-2021-financial-results-2021-07-29
https://www.nasdaq.com/press-release/hrs-2021%3a-ep-experts-to-demonstrate-the-benefits-of-acutus-medicals-complete-suite-of
https://www.nasdaq.com/press-release/alivecor-and-acutus-medical-partner-to-evaluate-management-and-treatment-of-cardiac
https://www.nasdaq.com/press-release/acutus-medical-inc.-announces-full-exercise-of-underwriters-option-to-purchase
https://www.nasdaq.com/press-release/acutus-medical-inc.-announces-pricing-of-public-offering-of-common-stock-2021-07-14
https://www.nasdaq.com/press-release/acutus-medical-inc.-announces-proposed-public-offering-of-common-stock-2021-07-12
https://www.nasdaq.com/press-release/acutus-medical-reports-preliminary-unaudited-second-quarter-2021-financial-results
https://www.nasdaq.com/press-release/acutus-medical-receives-fda-approval-to-initiate-us-atrial-fibrillation-ide-trial
https://www.nasdaq.com/press-release/acutus-medical-to-present-at-the-41st-annual-william-blair-growth-stock-conference
https://www.nasdaq.com/press-release/acutus-medical-announces-ce-mark-approval-for-suite-of-next-generation-ep-products-in
https://www.nasdaq.com/press-release/acutus-medical-reports-first-quarter-2021-financial-results-2021-05-13
https://www.nasdaq.com/press-release/acutus-medical-to-announce-first-quarter-2021-financial-results-2021-04-28
https://www.nasdaq.com/press-release/acutus-medical-to-participate-in-upcoming-investor-conferences-2021-04-20
https://www.nasdaq.com/press-release/acutus-medical-announces-fda-clearance-of-acqcrosstm-a-full-suite-of-universal
https://www.nasdaq.com/press-release/acutus-medical-initiates-first-ide-therapy-trial-with-the-acqblater-force-sensing
https://www.nasdaq.com/press-release/acutus-medical-to-present-at-the-20k-annual-needham-virtual-healthcare-conference
https://www.nasdaq.com/press-release/acutus-medical-reports-fourth-quarter-and-full-year-2020-financial-results-2021-03-18
https://www.nasdaq.com/press-release/acutus-medical-board-appoints-john-sheridan-as-a-new-director-2021-03-18
https://www.nasdaq.com/press-release/acutus-medical-announces-earnings-call-time-change-fourth-quarter-2020-earnings-call
https://www.nasdaq.com/press-release/acutus-medical-to-announce-fourth-quarter-and-full-year-2020-financial-results-2021
https://www.nasdaq.com/press-release/acutus-medical-receives-vizient-innovative-technology-contract-2021-03-02
https://www.nasdaq.com/press-release/acutus-medical-appoints-duane-wilder-as-chief-commercial-officer-2021-03-02
https://www.nasdaq.com/press-release/acutus-medical-inc.-appoints-new-chief-financial-officer-and-new-board-member-2021-02
https://www.nasdaq.com/press-release/acutus-medical-to-present-at-the-btig-virtual-medtech-digital-health-life-science-and
https://www.nasdaq.com/press-release/acutus-medical-suite-of-ep-products-to-be-featured-during-recorded-cases-at-af
https://www.nasdaq.com/press-release/acutus-medical-reports-preliminary-unaudited-fourth-quarter-and-full-year-2020
https://www.nasdaq.com/press-release/acutus-medical-to-present-at-the-j.p.-morgan-39th-annual-healthcare-conference-2020
https://www.nasdaq.com/press-release/acutus-medical-announces-ce-mark-and-european-launch-of-acqcrosstm-transseptal-system
https://www.nasdaq.com/press-release/acutus-medical-launches-acqblater-force-sensing-ablation-system-in-europe-2020-12-07
https://www.nasdaq.com/press-release/steven-mickelsen-md-joins-acutus-medical-as-chief-translational-science-officer-2020
https://www.nasdaq.com/press-release/acutus-medical-reports-third-quarter-2020-results-2020-11-12
https://www.nasdaq.com/press-release/acutus-medical-to-participate-at-the-canaccord-genuity-virtual-medtech-diagnostics
https://www.nasdaq.com/press-release/acutus-medical-to-announce-third-quarter-2020-financial-results-2020-10-29
https://www.nasdaq.com/press-release/acutus-medical-reports-second-quarter-2020-financial-results-2020-09-17
https://www.nasdaq.com/press-release/acutus-medical-announces-fda-clearance-of-second-generation-acqmap-3d-imaging-mapping
https://www.nasdaq.com/press-release/acutus-medical-announces-pulse-field-ablation-program-and-initial-pre-clinical
https://www.nasdaq.com/press-release/acutus-medical-to-announce-second-quarter-2020-financial-results-2020-09-03
